75 related articles for article (PubMed ID: 2941287)
1. Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis.
Davies BI; Maesen FP; Baur C
Eur J Clin Microbiol; 1986 Apr; 5(2):226-31. PubMed ID: 2941287
[TBL] [Abstract][Full Text] [Related]
2. Infection in acute exacerbations of chronic bronchitis: a clinical perspective.
Read RC
Respir Med; 1999 Dec; 93(12):845-50. PubMed ID: 10653044
[TBL] [Abstract][Full Text] [Related]
3. Ciprofloxacin in acute exacerbations of chronic bronchitis.
Hoogkamp-Korstanje JA; Klein SJ
J Antimicrob Chemother; 1986 Sep; 18(3):407-13. PubMed ID: 3490468
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin.
Gleadhill IC; Ferguson WP; Lowry RC
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():133-8. PubMed ID: 3804901
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute exacerbations of chronic bronchitis with ciprofloxacin.
Hoogkamp-Korstanje JA; Klein SJ
Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S60-3. PubMed ID: 3501857
[TBL] [Abstract][Full Text] [Related]
6. Systematic review: the bioavailability of orally administered antibiotics during the initial phase of a systemic infection in non-ICU patients.
van den Broek AK; Prins JM; Visser CE; van Hest RM
BMC Infect Dis; 2021 Mar; 21(1):285. PubMed ID: 33743592
[TBL] [Abstract][Full Text] [Related]
7. Oral fluoroquinolones in the treatment of pneumonia, bronchitis and sinusitis.
Mittmann N; Jivarj F; Wong A; Yoon A
Can J Infect Dis; 2002 Sep; 13(5):293-300. PubMed ID: 18159405
[TBL] [Abstract][Full Text] [Related]
8. Guide to selection of fluoroquinolones in patients with lower respiratory tract infections.
Shams WE; Evans ME
Drugs; 2005; 65(7):949-91. PubMed ID: 15892589
[TBL] [Abstract][Full Text] [Related]
9. Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.
Klepser ME; Ernst EJ; Petzold CR; Rhomberg P; Doern GV
Antimicrob Agents Chemother; 2001 Mar; 45(3):673-8. PubMed ID: 11181341
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection.
Lacy MK; Lu W; Xu X; Tessier PR; Nicolau DP; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1999 Mar; 43(3):672-7. PubMed ID: 10049286
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
Chodosh S; Lakshminarayan S; Swarz H; Breisch S
Antimicrob Agents Chemother; 1998 Jan; 42(1):114-20. PubMed ID: 9449270
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model.
Sullivan MC; Cooper BW; Nightingale CH; Quintiliani R; Lawlor MT
Antimicrob Agents Chemother; 1993 Feb; 37(2):234-9. PubMed ID: 8452353
[TBL] [Abstract][Full Text] [Related]
13. Penetration of ciprofloxacin into bronchial secretions from mechanically ventilated patients with nosocomial bronchopneumonia.
Saux P; Martin C; Mallet MN; Papazian L; Bruguerolle B; De Micco P; Gouin F
Antimicrob Agents Chemother; 1994 Apr; 38(4):901-4. PubMed ID: 8031070
[TBL] [Abstract][Full Text] [Related]
14. Penetration of ofloxacin into bronchial secretions.
Symonds J; Bone M; Turner A; Javaid A
Drugs; 1987; 34 Suppl 1():33-6. PubMed ID: 3481325
[TBL] [Abstract][Full Text] [Related]
15. Penetration of ofloxacin from blood to sputum.
Davies BI; Maesen FP; Geraedts WH; Baur C
Drugs; 1987; 34 Suppl 1():26-32. PubMed ID: 3481324
[TBL] [Abstract][Full Text] [Related]
16. Respiratory infections: clinical experiences with the new quinolones.
Davies BI; Maesen FP
Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S53-7. PubMed ID: 3438151
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis.
Jensen T; Pedersen SS; Høiby N; Koch C
Eur J Clin Microbiol; 1987 Dec; 6(6):618-22. PubMed ID: 3326741
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.
Paton JH; Reeves DS
Drugs; 1988 Aug; 36(2):193-228. PubMed ID: 3053126
[TBL] [Abstract][Full Text] [Related]
19. Overview of clinical experience with ciprofloxacin.
Ball AP
Eur J Clin Microbiol; 1986 Apr; 5(2):214-9. PubMed ID: 3013631
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
